高级检索
当前位置: 首页 > 详情页

Factors affecting recovery from anaesthesia with propofol-remifentanil target-controlled infusion in laparoscopic surgery

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Beijing Friendship Hospital, Capital Medical University, Beijing, PR China
出处:
ISSN:

关键词: Propofol target-controlled infusion effect-site concentration loss of consciousness return of consciousness

摘要:
Objective This study was performed to analyse factors influencing the effect-site concentration (Ce) of propofol at return of consciousness (ROC) with target-controlled infusion of propofol-remifentanil after laparoscopic surgery. Methods In total, 112 patients who underwent laparoscopic surgery under general anaesthesia were given propofol at the target concentration of 3.5 mu g/ml. Remifentanil (Ce: 4.0ng/ml) and 0.9mg/kg of rocuronium were administered when the Observer's Assessment of Alertness/Sedation score reached 1. Two minutes after injection of rocuronium, tracheal intubation was initiated. The bispectral index (BIS) was maintained between 45 and 55. Results Ce values of propofol at loss of consciousness (LOC) and ROC were significantly correlated. Age was significantly correlated with Ce of propofol at ROC. At LOC, propofol Ce values of patients aged 65-80, 45-64, and 20-44 years were 1.80.8, 2.2 +/- 0.7, and 2.3 +/- 0.8 mu g/ml, respectively, and the BIS was 70 +/- 10, 68 +/- 7, and 69 +/- 10, respectively. At ROC, the propofol Ce values of the three groups were 1.2 +/- 0.3, 1.4 +/- 0.3, and 1.5 +/- 0.3 mu g/ml, respectively, and the BIS was 80 +/- 5, 82 +/- 6, and 83 +/- 6, respectively. Conclusions The concentration of propofol at ROC was significantly affected by age, and ROC of propofol-remifentanil anaesthesia after laparoscopic surgery was well predicted by the concentration at LOC.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
JCR分区:
出版当年[2015]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q4 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Q4 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2015版] 出版当年五年平均[2011-2015] 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者单位: [1]Beijing Friendship Hospital, Capital Medical University, Beijing, PR China
通讯作者:
通讯机构: [1]Beijing Friendship Hospital, Capital Medical University, Beijing, PR China [*1]Beijing Friendship Hospital, Capital Medical University, Beijing 100050, PR China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)